[POM Wonderful LLC] asks a federal appeals court to vacate the Federal Trade Commission’s “draconian prohibition” requiring the pomegranate juice and supplement firm to support any disease-related health claim in advertising with at least two clinical randomized controlled trials.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?